Pioneering a new class of targeted medicines that deliver more. An Important Note About Privacy: Ring Therapeutics is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media platforms. We do not interview candidates on Telegram, Wire, Google Hangouts or similar public platforms. Any questions about job listings can be directed to careers@ringtx.com.
| Website | http://www.ringtx.com |
| Revenue | $23.2 million |
| Employees | 43 (37 on RocketReach) |
| Founded | 2017 |
| Phone | +1 617-949-5242 |
| Technologies |
JavaScript
,
HTML
,
Microsoft Outlook
+17 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Gene Therapy, Biotechnology, Genetic Medicine, Targeted Therapies, Gene Editing, Pharmaceutical, Drug Development, Cell Therapy, Precision Medicine, Dna Therapeutics, Regenerative Medicine, Oncology Therapeutics, Rare Diseases, Genome Engineering, Molecular Biology, Rna Therapeutics, Clinical Trials |
| Competitors | Novartis, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Sangamo Therapeutics, Inc., Editas Medicine, Intellia Therapeutics, Inc., CRISPR Therapeutics, Aptinyx Inc., bluebird bio +38 more (view full list) |
Looking for a particular Ring Therapeutics employee's phone or email?
The Ring Therapeutics annual revenue was $23.2 million in 2026.
Chris McNulty is the CEO of Ring Therapeutics.
37 people are employed at Ring Therapeutics.
Ring Therapeutics is based in Cambridge, Massachusetts.